These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22910039)

  • 1. Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activator.
    Mattmann ME; Yu H; Lin Z; Xu K; Huang X; Long S; Wu M; McManus OB; Engers DW; Le UM; Li M; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5936-41. PubMed ID: 22910039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and electrophysiological basis for the modulation of KCNQ1 channel currents by ML277.
    Willegems K; Eldstrom J; Kyriakis E; Ataei F; Sahakyan H; Dou Y; Russo S; Van Petegem F; Fedida D
    Nat Commun; 2022 Jun; 13(1):3760. PubMed ID: 35768468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ML277 regulates KCNQ1 single-channel amplitudes and kinetics, modified by voltage sensor state.
    Eldstrom J; McAfee DA; Dou Y; Wang Y; Fedida D
    J Gen Physiol; 2021 Dec; 153(12):. PubMed ID: 34636894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ML277 specifically enhances the fully activated open state of KCNQ1 by modulating VSD-pore coupling.
    Hou P; Shi J; White KM; Gao Y; Cui J
    Elife; 2019 Jul; 8():. PubMed ID: 31329101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do K
    Tsvetkov D; Kaßmann M; Tano JY; Chen L; Schleifenbaum J; Voelkl J; Lang F; Huang Y; Gollasch M
    Br J Pharmacol; 2017 Jan; 174(2):150-162. PubMed ID: 28000293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tanfelam: synthesis, study of ovicidal activity, and acute toxicity].
    Mikhaĭlitsyn FS; Fedianina LV; Bolotina LA; Lebedeva MN; Lychko ND
    Med Parazitol (Mosk); 2000; (1):26-7. PubMed ID: 10808714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly.
    Schwake M; Jentsch TJ; Friedrich T
    EMBO Rep; 2003 Jan; 4(1):76-81. PubMed ID: 12524525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.
    Yeung SY; Pucovský V; Moffatt JD; Saldanha L; Schwake M; Ohya S; Greenwood IA
    Br J Pharmacol; 2007 Jul; 151(6):758-70. PubMed ID: 17519950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
    Yeung S; Schwake M; Pucovský V; Greenwood Ia
    Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel activator of KCNQ1-KCNE1 K channel complexes.
    Mruk K; Kobertz WR
    PLoS One; 2009; 4(1):e4236. PubMed ID: 19156197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Bromo-2-(piperidin-1-yl)thiazol-5-yl-phenyl methanone (12b) inhibits Na+/K(+)-ATPase and Ras oncogene activity in cancer cells.
    Lefranc F; Xu Z; Burth P; Mathieu V; Revelant G; de Castro Faria MV; Noyon C; Garcia DG; Dufour D; Bruyère C; Gonçalves-de-Albuquerque CF; Van Antwerpen P; Rogister B; Hesse S; Kirsch G; Kiss R
    Eur J Med Chem; 2013 May; 63():213-23. PubMed ID: 23474907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological dissection of K(v)7.1 channels in systemic and pulmonary arteries.
    Chadha PS; Zunke F; Davis AJ; Jepps TA; Linders JT; Schwake M; Towart R; Greenwood IA
    Br J Pharmacol; 2012 Jun; 166(4):1377-87. PubMed ID: 22251082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of S4 charges in voltage-dependent and voltage-independent KCNQ1 potassium channel complexes.
    Panaghie G; Abbott GW
    J Gen Physiol; 2007 Feb; 129(2):121-33. PubMed ID: 17227916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener.
    Yu H; Wu M; Townsend SD; Zou B; Long S; Daniels JS; McManus OB; Li M; Lindsley CW; Hopkins CR
    ACS Chem Neurosci; 2011 Oct; 2(10):572-577. PubMed ID: 22125664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
    Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels.
    Gentles RG; Grant-Young K; Hu S; Huang Y; Poss MA; Andres C; Fiedler T; Knox R; Lodge N; Weaver CD; Harden DG
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5316-9. PubMed ID: 18774291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural mechanisms for the activation of human cardiac KCNQ1 channel by electro-mechanical coupling enhancers.
    Ma D; Zhong L; Yan Z; Yao J; Zhang Y; Ye F; Huang Y; Lai D; Yang W; Hou P; Guo J
    Proc Natl Acad Sci U S A; 2022 Nov; 119(45):e2207067119. PubMed ID: 36763058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
    Schwake M; Athanasiadu D; Beimgraben C; Blanz J; Beck C; Jentsch TJ; Saftig P; Friedrich T
    J Neurosci; 2006 Apr; 26(14):3757-66. PubMed ID: 16597729
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.